SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
Valuation | |
---|---|
Market Cap ($M) | 2.52 |
Enterprise Value ($M) | 13.43 |
Book Value ($M) | 3.39 |
Book Value / Share | 6.65 |
Price / Book | 0.74 |
NCAV ($M) | -23.64 |
NCAV / Share | -46.35 |
Price / NCAV | -0.11 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -1.00 |
Return on Assets (ROA) | -0.58 |
Return on Equity (ROE) | -2.89 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.35 |
Current Ratio | 1.35 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 5.38 |
Assets | 32.41 |
Liabilities | 29.02 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | -16.84 |
Net Income | -20.29 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -13.44 |
Cash from Investing | -0.01 |
Cash from Financing | 11.60 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Lincoln Park Capital Fund, LLC | 6.18 | -26.11 | |
13G/A | Lind Global Fund II LP | 5.30 | -38.94 | |
13G | Flynn James E | 7.59 | ||
13G | Duvvuri Krishna | 6.35 | ||
13D/A | Huang James | 1.50 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
6,892 | 28,870 | 23.87 | |
48,107 | 125,246 | 38.41 | |
12,242 | 5,487 | 223.11 | |
14,443 | 10,149 | 142.31 | |
(click for more detail) |
Similar Companies | |
---|---|
VTVT – vTv Therapeutics Inc. | VXRT – Vaxart, Inc. |
VYNE – VYNE Therapeutics Inc. | XBIO – Xenetic Biosciences, Inc. |
XCUR – Exicure, Inc. |
Financial data and stock pages provided by
Fintel.io